IP Library Granted Patent US 8,545,920
Granted Patent B2
US 8,545,920 · App. 11/947,580 · Granted Oct 1, 2013

Human milk compositions and methods of making and using same

Inventors: Elena M. Medo (Murrieta, CA); Martin L. Lee (Studio City, CA); David J. Rechtman (Hermosa Beach, CA); Joseph Fournell (Newbury Park, CA)
Assignee: Prolacta Bioscience Inc.
A23C9/206A23L1/30A23L1/302
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,545,920
App. No.
11/947,580
Granted
Oct 1, 2013
Kind
B2
Abstract

The disclosure features human milk fortifier compositions, standardized human milk, and methods of making and using same. In one embodiment, a pasteurized human milk composition includes a human protein constituent of about 35-85 mg/mL; a human fat constituent of about 60-110 mg/mL; and a human carbohydrate constituent of about 60-140 mg/mL.

Claims (28)

1. A pasteurized human milk composition comprising:

a human protein constituent of about 55-95 mg/ml;

a human fat constituent of about 85-95 mg/mL; and

a human carbohydrate constituent of about 70-120 mg/mL.

2. The composition of claim 1 , wherein the carbohydrate constituent comprises lactose.

3. The composition of claim 1 , further comprising one or more constituents selected from the group consisting of: calcium, chloride, copper, iron, magnesium, manganese, phosphorus, potassium, sodium, and zinc.

4. The composition of claim 1 , comprising:

calcium concentration of about 4.0-5.5 mg/mL;

chloride concentration of about 0.35-0.95 mg/mL;

copper concentration of about 0.0005-0.0021 mg/mL;

iron concentration of about 0.001-0.007 mg/mL;

magnesium concentration of about 0.180-0.292 mg/mL;

manganese concentration of about 0.010-0.092 micrograms/mL;

phosphorus concentration of about 2.00-3.05 mg/mL;

potassium concentration of about 1.90-2.18 mg/mL;

sodium concentration of about 0.75-0.96 mg/mL; and

zinc concentration of about 0.0200-0.0369 mg/mL.

5. The composition of claim 1 , comprising:

calcium concentration of about 2.00-2.90 mg/mL;

chloride concentration of about 0.175-0.475 mg/mL;

copper concentration of about 0.00025-0.001 mg/mL;

iron concentration of about 0.0005-0.0025 mg/mL;

magnesium concentration of about 0.090-0.170 mg/mL;

manganese concentration of about 0.005-0.046 micrograms/mL;

phosphorus concentration of about 1.00-1.50 mg/mL;

potassium concentration of about 0.95-1.41 mg/mL;

sodium concentration of about 0.375-0.608 mg/mL; and

zinc concentration of about 0.010-0.0198 mg/mL.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jun 5, 2026
From: HAYFIN SERVICES LLP, AS AGENT
To: PROLACTA BIOSCIENCE, INC.
Reel/Frame 074862/0454 →
SECURITY INTEREST Recorded Jun 5, 2026
From: PROLACTA BIOSCIENCE, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 074871/0441 →
SECURITY INTEREST Recorded Dec 21, 2023
From: PROLACTA BIOSCIENCE, INC.
To: HAYFIN SERVICES LLP, AS COLLATERAL AGENT
Reel/Frame 065935/0511 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2008
From: MEDO, ELENA M.; LEE, MARTIN L.; RECHTMAN, DAVID J.; FOURNELL, JOSEPH
To: PROLACTA BIOSCIENCE, INC.
Reel/Frame 020436/0316 →
Continuity (3)
Provisional Application 60867748 · Nov 29, 2006
Provisional Application 60841371 · Aug 30, 2006
Related Publication 20080124430A1 · May 29, 2008